Seeking Alpha

Shares of Sequenom (SQNM) are down 32% premarket following Wednesday evening's Q2 report....

Shares of Sequenom (SQNM) are down 32% premarket following Wednesday evening's Q2 report. Investors are nervous about comments the company made regarding delays in test payments. For more, see the Q&A on the conference call, notably the back and forth between management and Jefferies' Brandon Couillard. (transcript)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|